The National Institute of Diabetes and Digestive and Kidney Diseases offers small R01 grants for pilot and feasibility clinical trials targeting diseases within its mission. These grants aim to support short-term human trials to gather preliminary data on interventions related to disease prevention and treatment. Applicants must have clear objectives with potential to lead to larger, hypothesis-driven trials. Preliminary intervention efficacy data is not mandatory. Closing date for submissions is May 07, 2023.
Opportunity ID: 325922
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAS-20-160 |
| Funding Opportunity Title: | Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 31, 2020 |
| Last Updated Date: | Mar 31, 2020 |
| Original Closing Date for Applications: | May 07, 2023 |
| Current Closing Date for Applications: | May 07, 2023 |
| Archive Date: | Jun 12, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses State governments Independent school districts Special district governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities County governments Private institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement encourages the submission of pilot and feasibility clinical trials conducted in humans that will lay the foundation for larger clinical trials related to the prevention and/or treatment of diseases and conditions within the mission of NIDDK. The program will support small, short-term clinical trials in humans to acquire preliminary data regarding the effects of the intervention, as well as feasibility data related to recruitment and retention, and study conduct. Applications for clinical trials submitted under this FOA should have clearly described aims and objectives, and have a high likelihood that the trial findings will lead to more definitive, hypothesis-driven trialsto improve understanding, diagnosis, prevention or treatment of the diseases studied and have the potential to impact clinical practice and/or public health. Preliminary data regarding intervention efficacy a?r?e not required. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAS-20-160.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 325922 Full Announcement-PAS-20-160 -> PAS-20-160-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00260648 | May 05, 2020 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00269849 | Oct 28, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277834 | Nov 01, 2022 | May 07, 2023 | View |
Package 1
Mandatory forms
325922 RR_SF424_2_0-2.0.pdf
325922 PHS398_CoverPageSupplement_5_0-5.0.pdf
325922 RR_OtherProjectInfo_1_4-1.4.pdf
325922 PerformanceSite_2_0-2.0.pdf
325922 RR_KeyPersonExpanded_2_0-2.0.pdf
325922 PHS398_ResearchPlan_4_0-4.0.pdf
325922 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
325922 RR_Budget_1_4-1.4.pdf
325922 RR_SubawardBudget30_1_4-1.4.pdf
325922 PHS398_ModularBudget_1_2-1.2.pdf
325922 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
325922 RR_SF424_5_0-5.0.pdf
325922 PHS398_CoverPageSupplement_5_0-5.0.pdf
325922 RR_OtherProjectInfo_1_4-1.4.pdf
325922 PerformanceSite_4_0-4.0.pdf
325922 RR_KeyPersonExpanded_4_0-4.0.pdf
325922 PHS398_ResearchPlan_4_0-4.0.pdf
325922 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
325922 RR_Budget_3_0-3.0.pdf
325922 RR_SubawardBudget30_3_0-3.0.pdf
325922 PHS398_ModularBudget_1_2-1.2.pdf
325922 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
325922 RR_SF424_5_0-5.0.pdf
325922 PHS398_CoverPageSupplement_5_0-5.0.pdf
325922 RR_OtherProjectInfo_1_4-1.4.pdf
325922 PerformanceSite_4_0-4.0.pdf
325922 RR_KeyPersonExpanded_4_0-4.0.pdf
325922 PHS398_ResearchPlan_5_0-5.0.pdf
325922 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
325922 RR_Budget_3_0-3.0.pdf
325922 RR_SubawardBudget30_3_0-3.0.pdf
325922 PHS398_ModularBudget_1_2-1.2.pdf
325922 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
